ATE501T1 - Kolloide waessrige zusammensetzung fuer pharmazeutische zwecke, und deren herstellung. - Google Patents

Kolloide waessrige zusammensetzung fuer pharmazeutische zwecke, und deren herstellung.

Info

Publication number
ATE501T1
ATE501T1 AT79104378T AT79104378T ATE501T1 AT E501 T1 ATE501 T1 AT E501T1 AT 79104378 T AT79104378 T AT 79104378T AT 79104378 T AT79104378 T AT 79104378T AT E501 T1 ATE501 T1 AT E501T1
Authority
AT
Austria
Prior art keywords
production
aqueous compositions
pharmaceutical purposes
colloid aqueous
colloid
Prior art date
Application number
AT79104378T
Other languages
German (de)
English (en)
Inventor
Dieter Dr. Schmidt
Original Assignee
F. Hoffmann-La Roche & Co. Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche & Co. Aktiengesellschaft filed Critical F. Hoffmann-La Roche & Co. Aktiengesellschaft
Application granted granted Critical
Publication of ATE501T1 publication Critical patent/ATE501T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
AT79104378T 1978-11-21 1979-11-08 Kolloide waessrige zusammensetzung fuer pharmazeutische zwecke, und deren herstellung. ATE501T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1192178 1978-11-21
EP79104378A EP0011745B1 (de) 1978-11-21 1979-11-08 Kolloide wässrige Zusammensetzung für pharmazeutische Zwecke, und deren Herstellung

Publications (1)

Publication Number Publication Date
ATE501T1 true ATE501T1 (de) 1982-01-15

Family

ID=4378189

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79104378T ATE501T1 (de) 1978-11-21 1979-11-08 Kolloide waessrige zusammensetzung fuer pharmazeutische zwecke, und deren herstellung.

Country Status (22)

Country Link
US (1) US4271196A (id)
EP (1) EP0011745B1 (id)
JP (1) JPS5572111A (id)
KR (1) KR850000584B1 (id)
AR (1) AR225294A1 (id)
AT (1) ATE501T1 (id)
AU (1) AU529061B2 (id)
CA (1) CA1136988A (id)
DE (1) DE2961718D1 (id)
DK (1) DK494079A (id)
ES (1) ES8101855A1 (id)
FI (1) FI793461A (id)
GR (1) GR73668B (id)
HU (1) HU180792B (id)
IE (1) IE48659B1 (id)
IL (1) IL58723A (id)
MC (1) MC1297A1 (id)
NO (1) NO793759L (id)
NZ (1) NZ192118A (id)
PH (1) PH15561A (id)
PT (1) PT70478A (id)
ZA (1) ZA796116B (id)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
US4457918A (en) * 1982-05-12 1984-07-03 The General Hospital Corporation Glycosides of vitamins A, E and K
CA1237670A (en) * 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
US5231112A (en) 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
US4891208A (en) * 1985-04-10 1990-01-02 The Liposome Company, Inc. Steroidal liposomes
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
EP0682943B1 (de) * 1994-05-20 2003-08-20 GESELLSCHAFT FÜR MEDIZINISCHE FORSCHUNG UND WEITERBILDUNG e.V. GMF Lormetazepamhaltige Öl-in-Wasser-Emulsion
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US6576264B1 (en) 1995-10-17 2003-06-10 Skyepharma Canada Inc. Insoluble drug delivery
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
ES2201673T3 (es) * 1998-02-11 2004-03-16 Rtp Pharma Corporation Combinacion de esteroides y acidos grasos poiinsaturados para el tratamiento de estados inflamatorios.
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
JP2002516267A (ja) 1998-05-29 2002-06-04 アールティーピー・ファーマ・インコーポレーテッド 熱的に保護された微粒子組成物及びその最終蒸気滅菌
WO2000010531A1 (en) 1998-08-19 2000-03-02 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
PL201578B1 (pl) 1998-11-20 2009-04-30 Skyepharma Canada Inc Stała terapeutyczna postać dawkowania nierozpuszczalnego lub słabo rozpuszczalnego w wodzie związku
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
AU7984200A (en) * 1999-09-21 2001-04-24 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
AU2001257115B2 (en) 2000-04-20 2005-01-27 Rtp Pharma Inc. Improved water-insoluble drug particle process
CA2420597C (en) 2000-08-31 2011-05-17 Rtp Pharma Inc. Milled particles
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
TWI354568B (en) * 2000-09-20 2011-12-21 Jagotec Ag Insoluble drug particle compositions with improved
US6534088B2 (en) * 2001-02-22 2003-03-18 Skyepharma Canada Inc. Fibrate-statin combinations with reduced fed-fasted effects
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU29060A1 (id) *
LU28584A1 (id) *
FR2102537A5 (id) * 1970-08-07 1972-04-07 Ugine Kuhlmann
FR2270887A1 (en) * 1974-05-16 1975-12-12 Chabrier De Lassauniere Pierre Prepn of lecithins and glycol-lecithins - by reaction of trimethylamine with 2-substd-2-oxo-1,3,2-dioxaphospholans
SE442014B (sv) * 1976-10-12 1985-11-25 Barry D Sears Syntetisk fosfatidyl-kvarter ammoniumforening till anvendning for solubilisering eller emulgering av vattenolosliga foreningar

Also Published As

Publication number Publication date
FI793461A (fi) 1980-05-22
EP0011745A1 (de) 1980-06-11
ZA796116B (en) 1980-11-26
DE2961718D1 (en) 1982-02-18
IL58723A0 (en) 1980-02-29
NZ192118A (en) 1981-12-15
NO793759L (no) 1980-05-22
DK494079A (da) 1980-05-22
HU180792B (en) 1983-04-29
IE48659B1 (en) 1985-04-03
JPH0122243B2 (id) 1989-04-25
JPS5572111A (en) 1980-05-30
CA1136988A (en) 1982-12-07
GR73668B (id) 1984-03-28
EP0011745B1 (de) 1981-12-30
PH15561A (en) 1983-02-11
ES486157A0 (es) 1981-01-16
PT70478A (en) 1979-12-01
MC1297A1 (fr) 1980-10-03
IE792216L (en) 1980-05-21
US4271196A (en) 1981-06-02
AR225294A1 (es) 1982-03-15
IL58723A (en) 1982-11-30
ES8101855A1 (es) 1981-01-16
KR850000584B1 (ko) 1985-04-30
AU5282479A (en) 1980-05-29
AU529061B2 (en) 1983-05-26

Similar Documents

Publication Publication Date Title
ATE501T1 (de) Kolloide waessrige zusammensetzung fuer pharmazeutische zwecke, und deren herstellung.
NL980035I2 (nl) Benzimidazolen, de bereiding daarvan en deze verbindingen bevattende geneesmiddelen.
ATE37028T1 (de) Cephalosporinverbindungen, ihre herstellung, pharmazeutische praeparate und eingangsprodukte.
NL7904013A (nl) Farmaceutische verpakking.
ATE2616T1 (de) 1-aryl-2-acylamido-3-fluor-1-propanole, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IT7928464A0 (it) Composizione farmaceutica avente attivita' antitumorale.
DE3669315D1 (de) Phenoxyalkylaminopyrimidinderivate, deren herstellung und diese enthaltende insektizide und akarizide zusammensetzungen.
FR2432511B1 (fr) Derives triazoliques, leur preparation et leur application en tant que medicaments
DK154186C (da) Lamineret, let oploeseligt farmaceutisk enhedsdosisformlegeme
DE3280173D1 (de) Superoxid-dismutase, ihre herstellung und dieselbe enthaltende pharmazeutische zusammensetzungen.
IT7927614A0 (it) 1,2,4,5-tetra-alchil-4-arilpiperidi ne e relative formulazioni farmaceutiche.
IT7926662A0 (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline.
MX9203148A (es) 2,6-dialcoxipenzamidas y composiciones farmaceuticas que las contienen.
NL191108C (nl) Farmaceutische waterige cis-platin oplossing.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE2524T1 (de) Phenyliminothiazolinderivate, ihre herstellung und zwischenprodukte dafuer, sie enthaltende pharmazeutische praeparate und deren herstellung.
IT1122914B (it) 2-amminoetil-1-fenil-indoline,loro preparazione e loro applicazione come medicamenti
NL930014I2 (nl) 2,4-Dichloor-alpha(N-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat.
ATE8460T1 (de) Pharmazeutische praeparate und deren herstellung.
NL190120C (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan.
NL176076B (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat.
NL175525C (nl) Farmaceutisch preparaat met antibacteriele werking, alsmede met een acylaminogroep gesubstitueerd oleandomycinederivaat.
IT7921115A0 (it) Derivati di ciclitolammine ad azione farmaceutica.
ATE1011T1 (de) 5-fluoruracil-derivate, deren herstellung und ihre pharmazeutischen zusammensetzungen.
BE840411A (fr) Derives de la dicyclohexyl-3,3 propylamine utilisables comme medicaments

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee